David Ebersman is executive vice president and chief financial officer (CFO). As CFO, Ebersman is responsible for Genentech's Finance, General Audit, Investor Relations, Corporate Relations and Corporate Information Technology groups. Ebersman is a member of Genentech's executive committee.

Ebersman joined Genentech in 1994 as a business development analyst. During the next several years, he was promoted to positions of increasing responsibility in Business Development, Product Development and Product Operations. Ebersman served as vice president, Product Development; senior vice president, Product Operations; and senior vice president, Finance. In March 2005, Ebersman was appointed CFO and, in January 2006, he was promoted to executive vice president.

Prior to joining Genentech, Ebersman was a research analyst covering biotechnology investments for Oppenheimer & Co., Inc., an investment banking firm.

Ebersman holds a Bachelor of Arts in economics and international relations from Brown University.